Allarity Therapeutics, Inc. (ALLR)
1.31
+0.05
(+3.80%)
USD |
NASDAQ |
Sep 10, 09:30
Allarity Therapeutics Total Liabilities (Quarterly) : 28.58M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.58M |
| March 31, 2026 | 28.00M |
| December 31, 2025 | 8.43M |
| September 30, 2025 | 8.785M |
| June 30, 2025 | 9.038M |
| March 31, 2025 | 11.06M |
| December 31, 2024 | 10.84M |
| September 30, 2024 | 7.414M |
| June 30, 2024 | 11.05M |
| March 31, 2024 | 18.44M |
| December 31, 2023 | 14.61M |
| Date | Value |
|---|---|
| September 30, 2023 | 17.25M |
| June 30, 2023 | 14.15M |
| March 31, 2023 | 13.04M |
| December 31, 2022 | 12.65M |
| September 30, 2022 | 14.63M |
| June 30, 2022 | 13.15M |
| March 31, 2022 | 14.42M |
| December 31, 2021 | 30.85M |
| September 30, 2021 | 7.326M |
| June 30, 2021 | 9.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.12M |
| Shareholders Equity (Quarterly) | 3.536M |
| Debt to Equity Ratio | 6.303 |
| Current Ratio | 1.110 |
| Net Debt Paydown Yield | -20.39% |